Adaptive Biotechnologies Corp $ADPT

Recent News (9)

• Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference GlobeNewswire · 01 Sep 2026 SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune s…
• Adaptive Biotechnologies director Owen sells $249,990 in stock. Investing.com · 28 Aug 2026 Adaptive Biotechnologies director Owen sells $249,990 in stock.
• Adaptive Biotechnologies falls on earnings miss despite revenue beat Investing.com · 29 Jul 2026 Adaptive Biotechnologies falls on earnings miss despite revenue beat
• Earnings call transcript: Adaptive Biotechnologies misses Q2 2026 EPS, lifts revenue outlook Investing.com · 29 Jul 2026 Earnings call transcript: Adaptive Biotechnologies misses Q2 2026 EPS, lifts revenue outlook
• Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results GlobeNewswire · 29 Jul 2026 SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genet…
• Form 144 Adaptive Biotechnologies Corporation For: 21 July Investing.com · 22 Jul 2026 Form 144 Adaptive Biotechnologies Corporation For: 21 July
• Form 4 Adaptive Biotechnologies Corp For: 21 July Investing.com · 21 Jul 2026 Form 4 Adaptive Biotechnologies Corp For: 21 July
• Form 4 Adaptive Biotechnologies Corp For: 17 July Investing.com · 17 Jul 2026 Form 4 Adaptive Biotechnologies Corp For: 17 July
• Adaptive Biotechnologies CPO Lo reports $2.39m stock sale Investing.com · 17 Jul 2026 Adaptive Biotechnologies CPO Lo reports $2.39m stock sale